Markets:

Overview

News

Currencies

International

Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

11.09 +0.41 (+3.79%)

Streaming Delayed Price Updated: 11:27 AM EDT, May 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket ↗

June 06, 2023

Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading.

Via Benzinga

Barnwell Industries And 3 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

May 30, 2023

The Dow Jones closed higher by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

May 25, 2023

The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Over $2.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

May 24, 2023

The Dow Jones closed lower by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Recap: Bioventus Q1 Earnings ↗

May 16, 2023

Via Benzinga

Earnings Preview: Bioventus ↗

May 15, 2023

Via Benzinga

Preview: Bioventus's Earnings ↗

March 30, 2023

Via Benzinga

Earnings Preview: Bioventus ↗

March 29, 2023

Via Benzinga

Bioventus Completes Divestiture of its Wound Business

May 23, 2023

From Bioventus, Inc.

Via GlobeNewswire

Bioventus Reports First Quarter Financial Results

May 16, 2023

From Bioventus, Inc.

Via GlobeNewswire

Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023

May 15, 2023

From Bioventus, Inc.

Via GlobeNewswire

Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023

May 11, 2023

From Bioventus, Inc.

Via GlobeNewswire

Bioventus Announces Divestiture of its Wound Business

May 10, 2023

From Bioventus, Inc.

Via GlobeNewswire

Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

May 03, 2023

From Bioventus, Inc.

Via GlobeNewswire

Bioventus Inc. (NASDAQ:BVS) Long Term Investor Notice: Investigation of Potential Wrongdoing ↗

April 25, 2023

San Diego, CA -- (SBWIRE) -- 04/25/2023 -- An investigation was announced for long-term investors in shares of Bioventus Inc. (NASDAQ:BVS) concerning potential breaches of fiduciary duties by certain...

Via SBWire

Bioventus Announces CEO Leadership Change

April 05, 2023

From Bioventus, Inc.

Via GlobeNewswire

Last Day Of Q1 ↗

March 31, 2023

Wall Street bonuses fell 26% last year. This was the biggest drop since 2008. Wall Street is estimated to be responsible for 16% of all economic activity in NYC. Wild nights out for ibankers slowing...

Via Benzinga

Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results

March 31, 2023

From Bioventus, Inc.

Via GlobeNewswire

Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 31, 2023

Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.

Via Benzinga

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

March 31, 2023

From Bioventus, Inc.

Via GlobeNewswire

Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023

March 29, 2023

From Bioventus, Inc.

Via GlobeNewswire

Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023

March 16, 2023

From Bioventus, Inc.

Via GlobeNewswire

Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Bioventus Inc. (BVS) Investors of Class Action and Last Few Hours to Actively Participate

March 13, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

BVS DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important March 13 Deadline in Securities Class Action - BVS

March 12, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

BIOVENTUS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bioventus Inc. and Encourages Investors to Contact the Firm

March 10, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)

March 10, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

BVS MONDAY DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Bioventus Inc. Investors to Secure Counsel Before Important March 13 Deadline in Securities Class Action - BVS

March 09, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Southwest Airlines, Y-mAbs, Bioventus, and ESS and Encourages Investors to Contact the Firm

March 06, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Bioventus Inc. (BVS) Investors and Encourages Investors to Contact the Firm Before March 13, 2023

March 06, 2023

From Kirby McInerney LLP

Via Business Wire

BIOVENTUS INC. (NASDAQ: BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bioventus Inc. (NASDAQ: BVS)

March 06, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.